Literature DB >> 6661603

Caffeine and cerebral blood flow.

R J Mathew, D L Barr, M L Weinman.   

Abstract

Two groups of normal volunteers had regional cerebral blood flow (rCBF) measured, by the 133Xenon inhalation technique, before and 30 minutes after 250 mg or 500 mg caffeine given orally. rCBF was measured in a third group of subjects, twice, at a similar interval under identical laboratory conditions. Subjects who received caffeine showed significant decreases in rCBF while the others showed no rCBF change from the first to the second measurement. However, the two caffeine groups did not differ in degrees of rCBF reduction. There were no regional variations in the post-caffeine decrease in cerebral blood flow. The three groups did not show significant changes in end-tidal carbon dioxide, pulse rate, blood pressure, forehead skin temperature and respiratory rate.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6661603     DOI: 10.1192/bjp.143.6.604

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  12 in total

Review 1.  Single-photon emission computed tomography in neurotherapeutics.

Authors:  Michael D Devous
Journal:  NeuroRx       Date:  2005-04

2.  Caffeine alters proliferation of neuronal precursors in the adult hippocampus.

Authors:  Christian T Wentz; Sanjay S P Magavi
Journal:  Neuropharmacology       Date:  2009-02-13       Impact factor: 5.250

Review 3.  Caffeine and the control of cerebral hemodynamics.

Authors:  Dale A Pelligrino; Hao-Liang Xu; Francesco Vetri
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

4.  Quantification of indirect pathway inhibition by the adenosine A2a antagonist SYN115 in Parkinson disease.

Authors:  Kevin J Black; Jonathan M Koller; Meghan C Campbell; Debra A Gusnard; Stephen I Bandak
Journal:  J Neurosci       Date:  2010-12-01       Impact factor: 6.167

5.  The ability of denbufylline to inhibit cyclic nucleotide phosphodiesterase and its affinity for adenosine receptors and the adenosine re-uptake site.

Authors:  C D Nicholson; S A Jackman; R Wilke
Journal:  Br J Pharmacol       Date:  1989-07       Impact factor: 8.739

Review 6.  Pharmacological rationale for the clinical use of caffeine.

Authors:  J Sawynok
Journal:  Drugs       Date:  1995-01       Impact factor: 9.546

7.  Differential effects of methylxanthines on local cerebral blood flow and glucose utilization in the conscious rat.

Authors:  J J Grome; V Stefanovich
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-06       Impact factor: 3.000

8.  Caffeine withdrawal, acute effects, tolerance, and absence of net beneficial effects of chronic administration: cerebral blood flow velocity, quantitative EEG, and subjective effects.

Authors:  Stacey C Sigmon; Ronald I Herning; Warren Better; Jean L Cadet; Roland R Griffiths
Journal:  Psychopharmacology (Berl)       Date:  2009-02-25       Impact factor: 4.530

9.  Caffeine-induced cerebral blood flow changes in schizophrenia.

Authors:  R J Mathew; W H Wilson; S Tant
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1986

10.  Dextroamphetamine-induced changes in regional cerebral blood flow.

Authors:  R J Mathew; W H Wilson
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.